These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 11153779)

  • 21. Significance of a coronary artery with thrombolysis in myocardial infarction grade 2 flow "patency" (outcome in the thrombolysis and angioplasty in myocardial infarction trials). Thrombolysis and Angioplasty in Myocardial Infarction Study Group.
    Lincoff AM; Topol EJ; Califf RM; Sigmon KN; Lee KL; Ohman EM; Rosenschein U; Ellis SG
    Am J Cardiol; 1995 May; 75(14):871-6. PubMed ID: 7732992
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Admission troponin T level predicts clinical outcomes, TIMI flow, and myocardial tissue perfusion after primary percutaneous intervention for acute ST-segment elevation myocardial infarction.
    Giannitsis E; Müller-Bardorff M; Lehrke S; Wiegand U; Tölg R; Weidtmann B; Hartmann F; Richardt G; Katus HA
    Circulation; 2001 Aug; 104(6):630-5. PubMed ID: 11489766
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Determinants of myocardial salvage during acute myocardial infarction: evaluation with a combined angiographic and CMR myocardial salvage index.
    Ortiz-Pérez JT; Lee DC; Meyers SN; Davidson CJ; Bonow RO; Wu E
    JACC Cardiovasc Imaging; 2010 May; 3(5):491-500. PubMed ID: 20466344
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mean platelet volume is associated with poor postinterventional myocardial blush grade in patients with ST-segment elevation myocardial infarction.
    Sarli B; Baktir AO; Saglam H; Arinc H; Kurtul S; Sivgin S; Akpek M; Kaya MG
    Coron Artery Dis; 2013 Jun; 24(4):285-9. PubMed ID: 23542159
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of the angiographic myocardial blush grade with delayed-enhanced cardiac magnetic resonance for the assessment of microvascular obstruction in acute myocardial infarctions.
    Vicente J; Mewton N; Croisille P; Staat P; Bonnefoy-Cudraz E; Ovize M; Revel D
    Catheter Cardiovasc Interv; 2009 Dec; 74(7):1000-7. PubMed ID: 19626683
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Remote ischemic post-conditioning of the lower limb during primary percutaneous coronary intervention safely reduces enzymatic infarct size in anterior myocardial infarction: a randomized controlled trial.
    Crimi G; Pica S; Raineri C; Bramucci E; De Ferrari GM; Klersy C; Ferlini M; Marinoni B; Repetto A; Romeo M; Rosti V; Massa M; Raisaro A; Leonardi S; Rubartelli P; Oltrona Visconti L; Ferrario M
    JACC Cardiovasc Interv; 2013 Oct; 6(10):1055-63. PubMed ID: 24156966
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Frame counting improves the assessment of post-reperfusion microvascular patency by TIMI myocardial perfusion grade: Evidence from cardiac magnetic resonance imaging.
    Ge H; Ding S; An D; Li Z; Ding H; Yang F; Kong L; Xu J; Pu J; He B
    Int J Cardiol; 2016 Jan; 203():360-6. PubMed ID: 26539957
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Residual flow to the infarct zone as a determinant of infarct size after direct angioplasty.
    Clements IP; Christian TF; Higano ST; Gibbons RJ; Gersh BJ
    Circulation; 1993 Oct; 88(4 Pt 1):1527-33. PubMed ID: 8403301
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Determinants of infarct size in reperfusion therapy for acute myocardial infarction.
    Christian TF; Schwartz RS; Gibbons RJ
    Circulation; 1992 Jul; 86(1):81-90. PubMed ID: 1617793
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of tirofiban therapy on ST segment resolution and clinical outcomes in patients with ST segment elevated acute myocardial infarction undergoing primary angioplasty.
    Uyarel H; Uzunlar B; Unal Dayi S; Tartan Z; Samur H; Kasikcioglu H; Akgul O; Simsek D; Erdem I; Okmen E; Cam N
    Cardiology; 2006; 105(3):168-75. PubMed ID: 16479104
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The no-reflow phenomenon: epidemiology, pathophysiology, and therapeutic approach.
    Alfayoumi F; Srinivasan V; Geller M; Gradman A
    Rev Cardiovasc Med; 2005; 6(2):72-83. PubMed ID: 15976730
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of time-to-treatment on myocardial perfusion after primary percutaneous coronary intervention with Gp IIb-IIIa inhibitors.
    De Luca G; Gibson MC; Hof AW; Cutlip D; Zeymer U; Noc M; Maioli M; Zorman S; Gabriel MH; Secco GG; Emre A; Dudek D; Rakowski T; Gyongyosi M; Huber K; Bellandi F;
    J Cardiovasc Med (Hagerstown); 2013 Nov; 14(11):815-20. PubMed ID: 23519096
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The extent of microvascular damage during myocardial contrast echocardiography is superior to other known indexes of post-infarct reperfusion in predicting left ventricular remodeling: results of the multicenter AMICI study.
    Galiuto L; Garramone B; Scarà A; Rebuzzi AG; Crea F; La Torre G; Funaro S; Madonna M; Fedele F; Agati L;
    J Am Coll Cardiol; 2008 Feb; 51(5):552-9. PubMed ID: 18237684
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Determinants and prognostic implications of persistent ST-segment elevation after primary angioplasty for acute myocardial infarction: importance of microvascular reperfusion injury on clinical outcome.
    Claeys MJ; Bosmans J; Veenstra L; Jorens P; De RaedtH ; Vrints CJ
    Circulation; 1999 Apr; 99(15):1972-7. PubMed ID: 10209000
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of direct stenting on epicardial and myocardial perfusion in patients with acute ST segment elevation myocardial infarction.
    Gasior M; Gierlotka M; Pres D; Lekston A; Zebik T; Hawranek M; Tajstra M; Stasik-Pres G; Kalarus Z; Poloński L
    Kardiol Pol; 2007 May; 65(5):503-12; discussion 513-4. PubMed ID: 17577847
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of multivessel disease on myocardial perfusion and survival among patients undergoing primary percutaneous coronary intervention with glycoprotein IIb/IIIa inhibitors.
    De Luca G; Gibson M; Cutlip D; Huber K; Dudek D; Bellandi F; Noc M; Maioli M; Zorman S; Zeymer U; Secco GG; Mesquita Gabriel H; Emre A; Arntz HR; Rakowski T; Gyongyosi M; Hof AW;
    Arch Cardiovasc Dis; 2013 Mar; 106(3):155-61. PubMed ID: 23582677
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reperfusion injury in acute myocardial infarction: from bench to cath lab. Part II: Clinical issues and therapeutic options.
    Monassier JP
    Arch Cardiovasc Dis; 2008 Sep; 101(9):565-75. PubMed ID: 19041841
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of glycoprotein IIb/IIIa inhibition on microvascular flow after coronary reperfusion. A quantitative myocardial contrast echocardiography study.
    Kunichika H; Ben-Yehuda O; Lafitte S; Kunichika N; Peters B; DeMaria AN
    J Am Coll Cardiol; 2004 Jan; 43(2):276-83. PubMed ID: 14736449
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The target of reperfusion in acute coronary ischemic syndrome with ST segment elevation. The major paradigm: "Beyond TIMI 3 flow: the TIMI 4 or myocardial tissue-level perfusion"].
    Lupi-Herrera E; González Pacheco H; Juárez Herrera U; Chuquiure E; Vieyra G; Martínez Sánchez C
    Arch Cardiol Mex; 2002; 72(4):311-49. PubMed ID: 12613441
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Relationship of TIMI myocardial perfusion grade to mortality after administration of thrombolytic drugs.
    Gibson CM; Cannon CP; Murphy SA; Ryan KA; Mesley R; Marble SJ; McCabe CH; Van De Werf F; Braunwald E
    Circulation; 2000 Jan; 101(2):125-30. PubMed ID: 10637197
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.